(Q30651263)

25 June 2017

title

Combined hydroxypropyl-beta-cyclodextrin and poly(alkylcyanoacrylate) nanoparticles intended for oral administration of saquinavir (English)

1 reference

25 June 2017

1 reference

0 references

Boudad H

1

1 reference

25 June 2017

Legrand P

2

1 reference

25 June 2017

Lebas G

3

1 reference

25 June 2017

Cheron M

4

1 reference

25 June 2017

Duchêne D

5

1 reference

25 June 2017

Ponchel G

6

1 reference

25 June 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

International Journal of Pharmaceutics

25 June 2017

published in

1 reference

25 June 2017

volume

218

1 reference

25 June 2017

issue

1-2

1 reference

25 June 2017

page(s)

113-124

1 reference

Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro.

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900622-6

7 January 2021

Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900622-6

7 January 2021

Cyclodextrins in targeting. Application to nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900622-6

7 January 2021

Induced circular dichroism study of the aqueous solution complexation of cello-oligosaccharides and related polysaccharides with aromatic dyes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900622-6

7 January 2021

Cyclodextrin-based controlled drug release system

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900622-6

7 January 2021

Determination of saquinavir in human plasma, saliva, and cerebrospinal fluid by ion-pair high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900622-6

7 January 2021

Solubilization of a tripeptide HIV protease inhibitor using a combination of ionization and complexation with chemically modified cyclodextrins

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900622-6

7 January 2021

pH-sensitive nanoparticles: an effective means to improve the oral delivery of HIV-1 protease inhibitors in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900622-6

7 January 2021

Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900622-6

7 January 2021

Recent developments in HIV protease inhibitor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900622-6

7 January 2021

Saquinavir. A review of its pharmacology and clinical potential in the management of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900622-6

7 January 2021

Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900622-6

7 January 2021

Combined poly(isobutylcyanoacrylate) and cyclodextrins nanoparticles for enhancing the encapsulation of lipophilic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900622-6

7 January 2021

Cyclodextrins: their future in drug formulation and delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900622-6

7 January 2021

Cyclodextrin Drug Carrier Systems

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900622-6

7 January 2021

Oral absorption of the HIV protease inhibitors: a current update

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900622-6

7 January 2021

10.1016/S0378-5173(01)00622-6

Identifiers

DOI

1 reference

25 June 2017

1 reference